The Program Committee is looking for late-breaking clinical science, follow-up data from major randomized trials, single or multicenter registries, and first-in-man experiences with novel devices or drugs. Submissions will be considered for oral presentation in a featured session.
- Submission is FREE!
- All accepted abstracts will be given the opportunity for simultaneous published in SCAI's official journal, JSCAI.
- All accepted presenters receive nontransferable complimentary registration.
Submissions will open Wednesday, February 2, 2022. Please check back for a submission link.